GN
Genetic Technologies Limited
GNTLF · OTC
$1.00 +0.00% (+$0.00)
Market Cap $1.87B
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 1,019.21x
P/S 192.87x
P/FFO N/A
Growth
78 /100
Growing Book val. growth 56.03%
Rev. growth 93.52%
FCF growth N/A
Profitability
16 /100
Weak Op. margin 126.23%
Gross margin 40.37%
FCF margin 100.41%
Quality
21 /100
Poor Asset turnover 1.56x
ROIC 429.44%
ROA 194.25%
Debt
46 /100
Moderate Int. coverage -231.79x
Debt/Equity 0.48x
Current ratio 0.88x
Stability
15 /100
Unstable EPS volatility 41.75%
Beta 0.16x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GNTLF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Kevin Camilleri
Employees
55
Headquarters
Maroochydore